[Complementary treatment methods for depression in children and adolescents]

Insights

Evidence for complementary treatments for childhood depression is limited due to poor quality studies. More research is needed to guide effective treatment planning for depressive disorders in children and adolescents.

Area of Science:

  • Child and Adolescent Psychiatry
  • Mental Health Research
  • Evidence-Based Medicine

Context:

  • Depressive disorders affect 1-3% of prepubertal and 6% of postpubertal children and adolescents globally.
  • These disorders significantly impair psychosocial development and increase morbidity and mortality.
  • Physicians often face uncertainty regarding effective treatment strategies and planning for pediatric depression.

Purpose:

  • To systematically review and summarize the evidence for complementary treatment methods for depressive disorders in children and adolescents.
  • To identify gaps in research and inform future treatment guidelines.

Summary:

  • A comprehensive literature search identified over 450 studies, primarily randomized controlled trials (RCTs).
  • Evidence for most complementary treatments (e.g., art therapy, music therapy, exercise, light therapy) is low or absent due to limited or low-quality studies.
  • Limited evidence suggests potential effectiveness for light therapy, relaxation, stress reduction, and sleep deprivation, but lacks sufficient data for practical guidance.

Impact:

  • Highlights the urgent need for high-quality, comparative studies on pediatric depression treatments, including complementary methods.
  • Informs clinicians about the current limitations in evidence for various complementary therapies.
  • Aims to improve treatment planning and outcomes for children and adolescents with depressive disorders.

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
977
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.6K
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K